Ardelyx

News

FDA panel backs Ardelyx CKD drug, despite agency concerns

While the FDA seems to remain sceptical about the clinical benefits of Ardelyx's chronic kidney disease (CKD) therapy Xphozah – having

News

Hard times at Ardelyx as FDA rejects kidney disease drug ten...

The FDA has taken a longer than usual look at Ardelyx's regulatory submission for tenapanor, a drug for high blood phosphate levels associated with chronic kidney disease (CKD), and found i

Views & Analysis

Ardelyx’s ambition to revolutionise kidney treatment

A therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company Ardelyx.

FDA panel backs Ardelyx CKD drug, despite agency concerns

Hard times at Ardelyx as FDA rejects kidney disease drug ten...

Ardelyx’s ambition to revolutionise kidney treatment

AI-powered triage is coming to the NHS App

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks